Related Subjects:
|Hypertension
|Acute Heart Failure
|Chronic Heart Failure
โ ๏ธ IV use must only be undertaken with close cardiac and physiological monitoring.
๐ About
Always check the BNF link here for up-to-date dosing.
- Beta-blockers block beta-adrenergic receptors in the heart, vessels, lungs, pancreas, and liver.
- Atenolol is more lipid-soluble, with potentially more CNS side effects.
- It is relatively cardio-selective (greater effect on ฮฒ1 than ฮฒ2 receptors).
๐ฏ Indications
- Hypertension โ lowers cardiac output, blocks peripheral receptors, reduces plasma renin activity (often effective at low dose).
- Angina โ reduces cardiac oxygen demand. โ ๏ธ Avoid verapamil co-prescription (risk of heart failure).
- Post-MI (STEMI/NSTEMI) โ reduces mortality.
- Arrhythmias โ decreases automaticity and AV conduction. May be used with or instead of digoxin for AF rate control.
- Thyrotoxicosis โ controls adrenergic symptoms (tachycardia, tremor).
- Heart failure โ only bisoprolol, carvedilol, and nebivolol (in โฅ70 years, mild/moderate HF) reduce mortality.
๐ Indications & Dosing Atenolol
- ACS/Post-MI/Arrhythmias (IV): 2.5โ5 mg slow IV over 5โ10 min (1 mg/min rate), may repeat after 15 min up to 10 mg.
- ACS/Post-MI (PO): 25โ100 mg daily.
- Hypertension: 25โ50 mg once daily.
- Angina: 50โ100 mg daily (single or divided doses).
- Arrhythmias (PO): 50โ100 mg daily (single or divided doses).
โ ๏ธ Dose range: Always confirm with the BNF or drug datasheet.
โ Contraindications
- Bradycardia (<60 bpm) or systolic BP <100 mmHg.
- Asthma/bronchospasm.
- Second- or third-degree heart block.
- Uncontrolled, decompensated, or acute severe heart failure.
- Severe hypotension.
- Phaeochromocytoma (unless combined with an ฮฑ-blocker).
- Sick sinus syndrome.
- Significant peripheral vascular disease.
- Diabetes mellitus (especially if also on thiazide diuretics โ masks hypoglycaemia).
- โ ๏ธ Concomitant use with verapamil (risk of complete heart block).
โ ๏ธ Side Effects
- Fatigue, lethargy.
- Cold peripheries, bradycardia, hypotension.
- Heart failure, conduction abnormalities.
- Bronchospasm.
- Impotence, reduced exercise tolerance.
- Worsening diabetic control (masks hypoglycaemia symptoms).
- Worsening of psoriasis in susceptible patients.
๐ References
- Atenolol in BNF
- Oxford Handbook of Clinical Medicine.
- ESC Guidelines on Hypertension & ACS.